EX-99.1 3 dex991.htm PRESS RELEASE PRESS RELEASE

Exhibit 99.1

 

For information, contact:

Media—Susan Moore (713) 309-4645

Investors—Doug Pike (713) 309-7141

 

Lyondell Reports Second Quarter 2003 Results

 

Ÿ   Equistar’s raw material advantage boosts results.
Ÿ   Customer inventory reductions weaken chemical and plastics demand while crude oil and natural gas prices remain high.
Ÿ   LCR achieves record crude processing rates.
Ÿ   Lyondell and Equistar maintain significant liquidity.

 

HOUSTON, July 24, 2003 – Lyondell Chemical Company (NYSE:LYO) today announced a net loss for the second quarter of $68 million or 43 cents per share. This compares to net income of $2 million or 2 cents per share for the second quarter of 2002, and net loss of $113 million or 70 cents per share in the first quarter of 2003.

 

Lyondell Earnings Summary

 

     2Q2003

    2Q2002

   1Q2003

   

1st Six
Months

2003


   

1st Six
Months

2002


 
     Millions of dollars except per share amounts  

Sales and other operating revenues

   $ 913     $ 843    $ 989     $ 1,902     $ 1,517  

Net income (loss)

     (68 )     2      (113 )     (181 )     (53 )

Basic and diluted net income (loss) per share (a)

     (0.43 )     0.02      (0.70 )     (1.13 )     (0.45 )

Weighted average shares outstanding (millions) (a)

     161.0       117.6      160.4       160.7       117.6  

(a)   Lyondell sold 8.28 million shares of common stock on July 1, 2002 in a public offering and issued 34 million shares of Series B common stock to Occidental on August 22, 2002 in connection with the purchase of Occidental’s 29.5% interest in Equistar. Lyondell paid a dividend to Occidental on June 30, 2003 by issuing 543,947 shares of Series B common stock to Occidental in lieu of a dividend payment in cash.

 

Compared to the second quarter of last year, the net loss increased primarily as a result of reduced profitability of the Intermediate Chemicals and Derivatives (IC&D) segment, largely from a combination of the expiration of a significant MTBE contract at the end of 2002 and lower MTBE market margins. Compared to the first quarter of this year, the key factor that contributed to the improved results was higher Equistar ethylene margins, particularly for ethylene produced from liquid raw materials (see Note 1). This raw material advantage was largely responsible for an improvement of approximately $100 million in Equistar’s net income. During the second quarter 2003, financings and restructuring costs reduced net income by $14 million or 9 cents per share. The year-to-date 2003 net loss increased to $181 million or $1.13 per share compared to a net loss of $53 million or 45 cents


per share for the prior year-to-date period, primarily as a result of lower MTBE performance in IC&D and higher losses from the Company’s Equistar ownership.

 

Supplemental Financial Data—Lyondell and Proportionate Share of Ventures

 

     2Q2003

   2Q2002

   1Q2003

  

1st Six
Months

2003


  

1st Six
Months

2002


     Millions of dollars
Proportionate sales and other operating revenues (a)    $ 2,571    $ 1,942    $ 2,841    $ 5,412    $ 3,517
Proportionate EBITDA (b)      161      217      78      239      356

(a)   Includes revenues from sales to affiliates. See page 8 for components of proportionate share of sales and other operating revenues.
(b)   See reconciliation of net income (loss) to proportionate EBITDA on page 9 and Lyondell’s income statement information on page 10.

 

“Results during the quarter showed improvement when compared to the past two quarters, but were below the level that we anticipated when we entered the quarter,” said Lyondell President and CEO Dan F. Smith. “Nonetheless, our continued focus on cash and liquidity allowed us to finish the second quarter with liquidity at Lyondell and Equistar at similar levels to those at the beginning of the year.”

 

“Equistar’s Gulf Coast olefin plants that can consume liquid raw materials demonstrated their differential cost advantage despite crude oil prices remaining stubbornly high, averaging close to $30 per barrel for the second quarter. This advantage was partially offset by depressed volumes in Equistar’s products and across the chemical industry, caused by post-Iraq war inventory reductions, the impact of SARS, and generally poor economic conditions. In our 100%-owned IC&D segment, propylene oxide and derivatives performed as expected, realizing a series of price increases in April; but the MTBE business did not improve significantly. LYONDELL-CITGO Refining (LCR) continued to have excellent operating performance and strong cash distributions.”

 

OUTLOOK

 

During the second quarter, product shipments in general demonstrated a slow but steady improvement, and thus far this trend has continued into the third quarter. The Company expects Equistar to continue to benefit from its liquid raw material advantage although to a somewhat reduced degree. IC&D has benefited from lower raw material costs thus far in the third quarter. The Company expects LCR’s performance to continue to be strong, assuming sustained deliveries of contract crude oil volumes.

 

2


“Third quarter performance will be largely dependent on the pace of global economic recovery,” Smith said. “Under a scenario of moderate economic recovery and improved global stability, we would expect both Lyondell and Equistar to benefit from strengthening volumes and moderating raw material prices. However, industry operating rates remain depressed and, therefore, it will be difficult to achieve and sustain margin improvements in the near term. The potential for continued raw material cost volatility represents an uncertainty for Equistar, but we believe that the fundamentals will continue to favor Equistar’s liquid-based olefins position.”

 

LYONDELL AND JOINT VENTURES

 

Lyondell’s operations comprise: Lyondell’s IC&D segment; Equistar, a joint venture with Millennium Chemicals Inc.; and LCR, a joint venture with CITGO Petroleum Corp.

 

Lyondell’s Intermediate Chemicals & Derivatives (IC&D) Segment—The IC&D segment includes propylene oxide (PO) and derivatives, MTBE, methanol, styrene and toluene di-isocyanate (TDI).

 

IC&D Financial Overview

     2Q2003

    2Q2002

   1Q2003

   

1st Six
Months

2003


   

1st Six
Months

2002


     Millions of dollars

Sales and other operating revenues

   $ 913     $ 843    $ 989     $ 1,902     $ 1,517

Operating income (loss) (a)

     (6 )     65      (18 )     (24 )     103

EBITDA(a)

     48       120      53       101       215

(a)   See reconciliation of Lyondell net income (loss) to EBITDA on page 9 and Lyondell IC&D operating income (loss) and net income (loss) on page 10.

 

For IC&D, the second quarter 2003 included costs of $5 million related to financing activities.

 

2Q03 vs. 2Q02—Reduced profitability of MTBE accounted for the majority of the decrease in operating income versus the second quarter of 2002. The lower MTBE profitability resulted from a combination of the expiration of a favorable contract with BP at the end of 2002, higher raw material and utility costs related to high U.S. natural gas prices, and weak MTBE market conditions partially related to reduced demand in California. IC&D operating income was also impacted by increased operating costs, largely due to the new BDO-2 plant. Overall volumes for PO and derivatives, as well as TDI, were relatively unchanged versus the year ago period. Styrene profitability was relatively unchanged.

 

3


2Q03 vs. 1Q03—Compared to the first quarter of 2003, IC&D’s operating loss improved by $12 million based on improved business results. PO and derivatives realized higher prices and margins in the second quarter but, as expected, this was offset by lower volumes driven by a seasonal decline in deicers and temporary shifts in demand patterns resulting from April 2003 price increases. MTBE benefited from increased sales volumes and moderately increased European margins while U.S. margins continued to be soft. Styrene showed moderate margin improvements, which were partially offset by reduced export volumes. However, TDI experienced both lower global sales volumes and lower European prices. Lyondell net income and IC&D EBITDA in first quarter 2003 included an $18 million gain related to the restructuring of the Nihon Oxirane joint venture in Asia.

 

Equistar Chemicals, LP—Lyondell owns a 70.5 percent interest in Equistar, which consists of the petrochemicals and polymers segments.

 

Equistar Financial Overview—100% Basis

     2Q2003

    2Q2002

    1Q2003

   

1st Six
Months

2003


   

1st Six
Months

2002


 
     Millions of dollars  

Sales and other operating revenues(a)

   $ 1,597     $ 1,462     $ 1,641     $ 3,238     $ 2,598  

Operating income (loss)

     24       22       (96 )     (72 )     (53 )

Net loss(b)

     (49 )     (28 )     (146 )     (195 )     (1,207 )

EBITDA(b)

     80       96       (19 )     61       95  

(a)   Includes revenues from sales to affiliates.
(b)   See reconciliation of Equistar net loss to EBITDA on page 9.

 

Equistar’s results in the second quarter 2003 included costs of $19 million related to financing activities.

 

2Q03 v. 2Q02—Compared to the second quarter of 2002, the current quarter was characterized by higher margins and lower volumes. The margin improvement primarily resulted from ethylene and polyethylene prices which were reported by Chemical Marketing Associates, Inc. (CMAI) to be an average 7 cents to 10 cents per pound higher than in the period a year ago. While purchased raw material prices were significantly higher for both liquid and natural gas-based raw materials in the second quarter of 2003, higher prices realized for Equistar’s co-products produced from processing liquid raw materials offset most of the increase in liquid raw material prices (See Note 2).

 

4


CMAI, an industry consultant, estimates that the average cost of producing ethylene across the industry increased by approximately 3.5 cents per pound compared to the second quarter of 2002. However, as a result of Equistar’s flexibility to process liquid raw materials, its equivalent costs only increased by approximately 2 cents per pound.

 

Offsetting the increased margins were reduced sales volumes of ethylene and derivative products (ethylene, ethylene oxygenates and polyethylene) which, when taken together, were 20 percent below year-ago levels. Polymer sales volumes also were negatively impacted by approximately 85 million pounds of lower polypropylene sales as a result of the first quarter 2003 sale of the Bayport polypropylene unit.

 

2Q03 v. 1Q03—Compared to the first quarter of 2003, Equistar’s performance improvement was primarily a function of the lower cost of ethylene production at its Gulf Coast liquid-based olefin plants. This raw material advantage was largely responsible for an improvement of approximately $100 million in Equistar’s net income. CMAI estimates that the average cost of producing ethylene across the industry decreased by approximately 5.4 cents per pound compared to the first quarter of 2003. However, as a result of Equistar’s flexibility to process liquid raw materials, its equivalent costs decreased by nearly 8 cents per pound. Complementing this improvement, CMAI estimates that polymer pricing averaged 3 cents per pound higher than the first quarter average price. The positive impacts of the lower ethylene production costs and higher polymer prices were partially offset by significant volume reductions in ethylene and derivatives. Taken as a group, Equistar’s ethylene and derivative products sales volumes were about 13 percent below first quarter 2003 sales levels. As noted above, Equistar’s polymers sales volumes were impacted by the first quarter 2003 sale of the Bayport polypropylene unit.

 

LYONDELL-CITGO Refining LP (LCR)—Lyondell owns a 58.75 percent interest in LCR, a major refiner of heavy crude oil.

 

LCR Financial Overview—100% Basis

     2Q2003

   2Q2002

   1Q2003

  

1st Six
Months

2003


  

1st Six
Months

2002


     Millions of dollars

Sales and other operating revenues(a)

   $ 905    $ 838    $ 1,183    $ 2,088    $ 1,545

Operating income

     67      70      38      105      119

Net income(b)

     58      63      28      86      104

EBITDA(b)

     96      100      66      162      178

(a)   Includes revenues from sales to affiliates.
(b)   See reconciliation of LCR net income to EBITDA on page 9.

 

5


LCR’s second quarter results were reduced by a $6 million restructuring charge related to personnel reductions.

 

2Q03 v. 2Q02—Compared to the second quarter of 2002, performance at LCR was relatively unchanged. LCR’s total crude processing rate increased by 15,000 barrels per day compared to the second quarter 2002, averaging 274,000 barrels per day. The amount of Venezuelan crude oil processed by LCR under the Crude Supply Agreement (CSA) with PDVSA was 45,000 barrels per day higher than in the second quarter of 2002, averaging 246,000 barrels per day. Offsetting these positives was the negative effect of higher gas costs and lower spot crude volumes.

 

2Q03 vs. 1Q03—In the first quarter of 2003, results were negatively impacted by a $25 million charge related to the restructuring of LCR’s low sulfur gasoline project. Compared to the first quarter, total crude processing rates increased 28,000 barrels per day and CSA crude processing rates increased 52,000 barrels per day. Lower volumes and margins related to spot crude purchases partially offset the benefit of the higher CSA processing rates.

 

CONFERENCE CALL

 

Lyondell will host a conference call today, July 24, 2003, at 11:30 a.m. Eastern Time (ET). Participating on the call will be: Dan Smith, President and CEO; Morris Gelb, Executive Vice President and COO; Kevin DeNicola, Senior Vice President and CFO; and Doug Pike, Director of Investor Relations. The dial-in numbers are 888-385-9734 (U.S – toll free) and 212-547-0409 (international). The passcode is LYONDELL. The call will be broadcast live on the Investor Relations page of the company’s web site at www.lyondell.com/earnings.

 

A replay of the call will be available from 1:30 p.m. ET July 24 to 5 p.m. ET August 1. The dial-in numbers are 800-925-2380 (U.S) and 402-220-4107 (international). Pass code for each is 5549. Web replay will be available at 1:30 p.m. ET July 24 on the Investor Relations page of the company’s web site at www.lyondell.com/earnings.

 

Reconciliations of non-GAAP financial measures to GAAP financial measures and any other applicable disclosures, including this earnings release, will be available at 11:30 a.m. ET at www.lyondell.com/earnings.

 

6


NOTE 1

 

“Liquid raw materials” include crude-oil-based liquids such as naphtha, condensates and gas oils. In contrast, “natural gas-based” raw materials include ethane, propane and butane which are sometimes referred to collectively as natural gas liquids (NGL’s). Equistar’s olefins facilities on the Texas Gulf Coast generally have the flexibility to use significant percentages of either liquid or natural gas based raw materials for the production of ethylene.

 

NOTE 2

 

The use of liquid raw materials results in the production of co-products such as propylene, butadiene, benzene and toluene. The use of natural gas-based raw materials does not produce significant volumes of these co-product materials.

 

ABOUT LYONDELL

 

Lyondell Chemical Company, (www.lyondell.com), headquartered in Houston, Texas, is a leading producer of: propylene oxide (PO); PO derivatives, including toluene diisocyanate (TDI), propylene glycol (PG), butanediol (BDO) and propylene glycol ether (PGE); and styrene monomer and MTBE as co-products of PO production. Through its 70.5% interest in Equistar Chemicals, LP, Lyondell also is one of the largest producers of ethylene, propylene and polyethylene in North America and a leading producer of ethylene oxide, ethylene glycol, high value-added specialty polymers and polymeric powder. Through its 58.75% interest in LYONDELL-CITGO Refining LP, Lyondell is one of the largest refiners in the United States processing extra heavy Venezuelan crude oil to produce gasoline, low sulfur diesel and jet fuel.

 

FORWARD LOOKING STATEMENTS

 

The statements in this release relating to matters that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to: the cyclical nature of the chemical and refining industries; availability, cost and volatility of raw materials and utilities; governmental regulatory actions and political unrest; global economic conditions; industry production capacity and operating rates; the supply/demand balance for Lyondell’s and its joint ventures’ products; competitive products and pricing pressures; access to capital markets; technological developments and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to Lyondell’s Annual Report on Form 10-K for the year ended December 31, 2002 and Lyondell’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003 which will be filed in August 2003.

 

###

 

7


LYONDELL CHEMICAL COMPANY

SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)

(Millions of dollars)

 

     Lyondell
Chemical
Company


    Joint Ventures

    Lyondell and
Proportionate
Share of Equity
Investments (a)


       Equistar
100%


    LCR
100%


   LMC
100%


   

Three months ended June 30, 2003:

                                     

Sales and other operating revenues (b)

   $ 913     $ 1,597     $ 905    $ —       $ 2,571

SG&A and R&D

     53       54       16      —         100

EBITDA

     48       80       96      —         161

Depreciation and amortization

     61       76       29      —         129

Interest expense, net

     99       53       9      —         142

Net loss

     (68 )(c)                             

Capital expenditures

     229  (d)(e)     21       13      —         251

Cash dividends

     29                               

Three months ended June 30, 2002:

                                     

Sales and other operating revenues (b)

   $ 843     $ 1,462     $ 838    $ 10     $ 1,942

SG&A and R&D

     54       50       14      1       83

EBITDA

     120       96       100      (2 )     217

Depreciation and amortization

     59       74       30      1       108

Interest expense, net

     91       50       7      —         116

Net income

     2  (c)                             

Capital expenditures

     1  (d)     14       20      —         18

Cash dividends

     27                               

Three months ended March 31, 2003:

                                     

Sales and other operating revenues (b)

   $ 989     $ 1,641     $ 1,183    $ —       $ 2,841

SG&A and R&D

     51       49       12      —         93

EBITDA

     53       (19 )     66      —         78

Depreciation and amortization

     57       78       28      —         126

Interest expense, net

     83       49       10      —         123

Net loss

     (113 )(c)                             

Capital expenditures

     9  (d)     13       15      —         27

Cash dividends

     28                               

(a)   This column reflects Lyondell’s 100% owned operations and its pro rata share of each joint venture’s operations and is not a presentation in accordance with generally accepted accounting principles. Lyondell had a 41% interest in Equistar Chemicals, LP (“Equistar”) through August 22, 2002 and 70.5% thereafter, a 58.75% interest in LYONDELL-CITGO Refining LP (“LCR”) and, through April 30, 2002, a 75% interest in LMC. As of May 1, 2002, Lyondell Methanol Company, L.P. (“LMC”) is wholly owned by Lyondell and its operations are included in the IC&D business segment.
(b)   Includes revenues from sales to affiliates.
(c)   Includes income (loss) in the joint ventures.
(d)   In addition, Lyondell made contributions to the PO-11 joint venture and the U.S. PO joint venture of $27 million, $10 million and $30 million in the three-month periods ended June 30, 2003, June 30, 2002 and March 31, 2003, respectively.
(e)   Capital expenditures of $229 million for the three months ended June 30, 2003 include Lyondell’s purchase of the BDO-2 facility from the lessor.

 

8


LYONDELL CHEMICAL COMPANY

SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)

(Millions of dollars)

 

RECONCILIATION OF NET INCOME (LOSS) TO EBITDA

 

     For the three months ended

   

For the six

months ended


 
     June 30,

    March 31,     June 30,

 
     2003

    2002

    2003

    2003

    2002

 

LYONDELL

                                        

Net income (loss)

   $ (68 )   $ 2     $ (113 )   $ (181 )   $ (53 )

Add:

                                        

Benefit from income taxes

     (39 )     —         (55 )     (94 )     (18 )

Interest expense, net

     99       91       83       182       182  

Depreciation and amortization

     61       59       57       118       115  

Loss from equity investment in Equistar

     32       5       100       132       50  

Income from equity investment in LCR

     (37 )     (39 )     (19 )     (56 )     (66 )

Loss from equity investment in LMC

     —         2       —         —         5  
    


 


 


 


 


IC&D EBITDA

   $ 48     $ 120     $ 53     $ 101     $ 215  
    


 


 


 


 


EQUISTAR

                                        

Net loss

   $ (49 )   $ (28 )   $ (146 )   $ (195 )   $ (1,207 )

Add:

                                        

Depreciation and amortization

     76       74       78       154       147  

Interest expense, net

     53       50       49       102       102  

Cumulative effect of accounting change

     —         —         —         —         1,053  
    


 


 


 


 


EBITDA

   $ 80     $ 96     $ (19 )   $ 61     $ 95  
    


 


 


 


 


Lyondell Proportionate Share (a)

   $ 57     $ 39     $ (13 )   $ 43     $ 39  
    


 


 


 


 


LCR

                                        

Net income

   $ 58     $ 63     $ 28     $ 86     $ 104  

Add:

                                        

Depreciation and amortization

     29       30       28       57       59  

Interest expense

     9       7       10       19       15  
    


 


 


 


 


EBITDA

   $ 96     $ 100     $ 66     $ 162     $ 178  
    


 


 


 


 


Lyondell Proportionate Share—58.75%

   $ 56     $ 59     $ 39     $ 95     $ 105  
    


 


 


 


 


EBITDA—Lyondell and Proportionate Share of Equity Investments

                                        

IC&D EBITDA

   $ 48     $ 120     $ 53     $ 101     $ 215  

Lyondell share of Equistar EBITDA (a)

     57       39       (13 )     43       39  

Lyondell 58.75% share of LCR EBITDA

     56       59       39       95       105  

Lyondell share of LMC EBITDA through April 30, 2002

     —         (1 )     —         —         (3 )
    


 


 


 


 


Lyondell and Proportionate Share of Equity Investments

   $ 161     $ 217     $ 78     $ 239     $ 356  
    


 


 


 


 



(a)   Lyondell has a 70.5% interest in Equistar. Prior to August 22, 2002, it had a 41% interest.

 

9


LYONDELL CHEMICAL COMPANY

SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)

 

     For the three months ended

    For the six months ended

 
     June 30,

    March 31,
2003


    June 30,

 
     2003

    2002

      2003

    2002

 
INCOME STATEMENT INFORMATION    (Millions of dollars, except per share data)  

Sales and other operating revenues

   $ 913     $ 843     $ 989     $ 1,902     $ 1,517  

Operating costs and expenses:

                                        

Cost of sales

     866       724       956       1,822       1,313  

Selling, general and administrative expenses

     45       46       42       87       86  

Research and development

     8       8       9       17       15  
    


 


 


 


 


Operating income (loss)

     (6 )     65       (18 )     (24 )     103  

Loss from equity investment in Equistar (a) (b)

     (32 )     (5 )     (100 )     (132 )     (50 )

Income from equity investment in LCR

     37       39       19       56       66  

Loss from other equity investments

     (4 )     (2 )     (2 )     (6 )     (5 )

Interest expense, net

     (99 )     (91 )     (83 )     (182 )     (182 )

Other income (expense), net

     (3 )     (4 )     16       13       (3 )
    


 


 


 


 


Income (loss) before income taxes

     (107 )     2       (168 )     (275 )     (71 )

Benefit from income taxes

     (39 )     —         (55 )     (94 )     (18 )
    


 


 


 


 


Net income (loss) (a)

   $ (68 )   $ 2     $ (113 )   $ (181 )   $ (53 )
    


 


 


 


 


Basic and diluted income (loss) per share:

                                        

Net income (loss) (a)

   $ (0.43 )   $ 0.02     $ (0.70 )   $ (1.13 )   $ (0.45 )
    


 


 


 


 


Shares (in thousands) (c) :

                                        

Basic

     161,023       117,565       160,419       160,722       117,565  
    


 


 


 


 


Diluted

     161,023       118,329       160,419       160,722       117,565  
    


 


 


 


 


INTERMEDIATE CHEMICALS AND DERIVATIVES SEGMENT

SELECTED OPERATING INFORMATION

Sales Volumes (millions)

                                        

PO and derivatives (pounds) (d)

     744       732       899       1,643       1,517  

Co-products:

                                        

Styrene monomer (pounds)

     780       864       869       1,649       1,650  

MTBE and other TBA derivatives (gallons)

     322       329       257       579       596  

(a)   As of January 1, 2002, Lyondell’s 41% share of Equistar’s $1.1 billion charge for the write-off of goodwill, or $432 million, was offset by Lyondell’s write-off of a portion of the excess of its underlying equity in Equistar’s net assets over its investment in Equistar.
(b)   Lyondell has a 70.5% interest in Equistar. Prior to August 22, 2002, it had a 41% interest.
(c)   Lyondell sold 8,280,000 shares of common stock on July 1, 2002 and issued 34,000,000 shares of Series B common stock to Occidental on August 22, 2002. Lyondell paid a dividend to Occidental on June 30, 2003 by issuing 543,947 shares of Series B common stock in lieu of a dividend payment in cash.
(d)   Includes propylene oxide (“PO”), PO derivatives and isocyanates.

 

10


LYONDELL CHEMICAL COMPANY

SELECTED FINANCIAL INFORMATION (UNAUDITED)

(Millions of dollars)

 

     For the six months
ended June 30,


 
CASH FLOW INFORMATION    2003

       2002

 

Net loss

   $ (181 )      $ (53 )

Adjustments:

                   

Depreciation and amortization

     118          115  

Loss from equity investments

     138          55  

Distributions from affiliates less than earnings

     —            (15 )

Gain on sale of investment

     (18 )        —    

Deferred income taxes

     (92 )        16  

Accounts receivable

     (4 )        23  

Inventories

     (14 )        11  

Accounts payable

     34          (2 )

Other assets and liabilities, net

     47          55  
    


    


Net cash provided by operating activities

     28          205  
    


    


Expenditures for property, plant and equipment

     (238 )        (12 )

Distributions from affiliates in excess of earnings

     102          —    

Contributions and advances to affiliates (a)

     (78 )        (54 )

Proceeds from sale of investment

     28          —    

Maturity of other short-term investments

     25          —    

Other

     —            (3 )
    


    


Net cash used in investing activities

     (161 )        (69 )
    


    


Issuance of long-term debt

     318          —    

Repayment of long-term debt

     (103 )        (16 )

Dividends paid

     (57 )        (53 )

Other

     (4 )        —    
    


    


Net cash provided by (used in) financing activities

     154          (69 )
    


    


Effect of exchange rate changes on cash

     1          2  
    


    


Increase in cash and cash equivalents

   $ 22        $ 69  
    


    



(a)   Includes contributions to PO-11 joint venture and U.S. PO joint venture of $57 million and $23 million in the six-month periods ended June 30, 2003 and 2002, respectively.

 

11


LYONDELL CHEMICAL COMPANY

SELECTED FINANCIAL INFORMATION (UNAUDITED)

(Millions of dollars)

 

BALANCE SHEET INFORMATION   

June 30,

2003


    December 31,
2002


 

Cash and cash equivalents

   $ 308     $ 286  

Other short-term investments

     19       44  

Accounts receivable, net

     381       396  

Inventories

     366       344  

Prepaid expenses and other current assets

     65       66  

Deferred tax assets

     35       35  
    


 


Total current assets

     1,174       1,171  

Property, plant and equipment, net

     2,596       2,369  

Investments and long-term receivables:

                

Investment in Equistar

     1,052       1,184  

Investment in PO joint ventures

     825       770  

Receivable from LCR

     229       229  

Investment in LCR

     1       68  

Other investments and long-term receivables

     78       98  

Goodwill, net

     1,135       1,130  

Other assets, net

     392       429  
    


 


Total assets

   $ 7,482     $ 7,448  
    


 


Accounts payable

   $ 396     $ 344  

Current maturities of long-term debt

     —         1  

Other accrued liabilities

     256       279  
    


 


Total current liabilities

     652       624  

Long-term debt

     4,150       3,926  

Other liabilities

     660       673  

Deferred income taxes

     807       881  

Minority interest

     148       165  

Stockholders’ equity (161,867,168 and 160,413,144 shares outstanding respectively at June 30, 2003 and December 31, 2002)

     1,065       1,179  
    


 


Total liabilities and stockholders’ equity

   $ 7,482     $ 7,448  
    


 


     For the three
months ended
June 30, 2003


    For the six
months ended
June 30, 2003


 

Investment in Equistar, beginning of period

   $ 1,084     $ 1,184  

Lyondell’s share of Equistar net loss

     (32 )     (132 )
    


 


Investment in Equistar, end of period

   $ 1,052     $ 1,052  
    


 


Investment in LCR, beginning of period

   $ 20     $ 68  

Lyondell’s share of LCR net income

     37       56  

Cash distributions from LCR

     (68 )     (156 )

Cash contributions to LCR

     —         21  

Contribution payable to LCR

     2       2  

Conversion of interest receivable from LCR to equity investment

     10       10  
    


 


Investment in LCR, end of period

   $ 1     $ 1  
    


 


 

12


LYONDELL CHEMICAL COMPANY

EQUISTAR CHEMICALS, LP

SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)

 

     For the three months ended

    For the six months ended

 
     June 30,

     March 31,
2003


    June 30,

 
     2003

     2002

       2003

     2002

 
     (Millions of dollars)  
INCOME STATEMENT INFORMATION                                            

Sales and other operating revenues (a)

   $ 1,597      $ 1,462      $ 1,641     $ 3,238      $ 2,598  

Operating costs and expenses:

                                           

Cost of sales

     1,519        1,390        1,688       3,207        2,552  

Selling, general and administrative expenses

     44        41        40       84        81  

Research and development

     10        9        9       19        18  
    


  


  


 


  


Operating income (loss)

     24        22        (96 )     (72 )      (53 )

Interest expense, net

     (53 )      (50 )      (49 )     (102 )      (102 )

Other income (expense), net

     (20 )      —          (1 )     (21 )      1  
    


  


  


 


  


Loss before cumulative effect of accounting change

     (49 )      (28 )      (146 )     (195 )      (154 )

Cumulative effect of accounting change (b)

     —          —          —         —          (1,053 )
    


  


  


 


  


Net loss (c)

   $ (49 )    $ (28 )    $ (146 )   $ (195 )    $ (1,207 )
    


  


  


 


  


SELECTED FINANCIAL AND OPERATING INFORMATION

                                           

Sales and other operating revenues (a)

                                           

Petrochemicals segment

   $ 1,481      $ 1,318      $ 1,536     $ 3,017      $ 2,311  

Polymers segment

     445        479        513       958        889  

Intersegment eliminations

     (329 )      (335 )      (408 )     (737 )      (602 )
    


  


  


 


  


Total

   $ 1,597      $ 1,462      $ 1,641     $ 3,238      $ 2,598  
    


  


  


 


  


Operating income (loss)

                                           

Petrochemicals segment

   $ 85      $ 79      $ (32 )   $ 53      $ 55  

Polymers segment

     (27 )      (26 )      (35 )     (62 )      (47 )

Unallocated

     (34 )      (31 )      (29 )     (63 )      (61 )
    


  


  


 


  


Total

   $ 24      $ 22      $ (96 )   $ (72 )    $ (53 )
    


  


  


 


  


EBITDA before cumulative effect of accounting change

   $ 80      $ 96      $ (19 )   $ 61      $ 95  

Sales Volumes (including intersegment sales) (millions) (a)

                                           

Selected petrochemical products:

                                           

Ethylene, propylene and other olefins (pounds)

     3,723        4,393        3,921       7,644        8,530  

Aromatics (gallons)

     98        103        94       192        189  

Polymers products (pounds)

     1,143        1,593        1,397       2,540        3,101  

(a)   Sales and other operating revenues include sales to affiliates. Sales volumes include sales volumes from sales to affiliates as well as intersegment sales volumes.
(b)   Concurrent with the adoption of SFAS No. 142, Equistar reviewed goodwill for impairment and concluded that the entire balance was impaired, resulting in the $1.1 billion charge.
(c)   As a partnership, Equistar is not subject to federal income taxes.

 

13


LYONDELL CHEMICAL COMPANY

EQUISTAR CHEMICALS, LP

SELECTED FINANCIAL INFORMATION (UNAUDITED)

(Millions of dollars)

 

BALANCE SHEET INFORMATION    June 30,
2003


   December 31,
2002


Cash and cash equivalents

   $ 143    $ 27

Accounts receivable, net (a)

     559      625

Inventories

     478      424

Prepaid expenses and other current assets

     36      50
    

  

Total current assets

     1,216      1,126

Property, plant and equipment, net

     3,405      3,565

Investments

     65      65

Other assets, net

     343      296
    

  

Total assets

   $ 5,029    $ 5,052
    

  

Accounts payable

   $ 482    $ 459

Current maturities of long-term debt

     31      32

Other accrued liabilities

     176      223
    

  

Total current liabilities

     689      714

Long-term debt

     2,223      2,196

Other liabilities

     391      221

Partners’ capital

     1,726      1,921
    

  

Total liabilities and partners’ capital

   $ 5,029    $ 5,052
    

  

 

    

For the three

months ended


   For the six
months ended


 
     June 30,

    March 31,
2003


   June 30,

 
OTHER INFORMATION    2003

   2002

       2003

   2002

 

Cash flow from operations (a) (b)

   $ 32    $ (20 )   $ 67    $ 99    $ (139 )

Capital expenditures

     21      14       13      34      29  

Depreciation and amortization:

                                     

Petrochemicals segment

   $ 56    $ 53     $ 57    $ 113    $ 106  

Polymers segment

     14      15       16      30      29  

Other

     6      6       5      11      12  
    

  


 

  

  


Total depreciation and amortization

   $ 76    $ 74     $ 78    $ 154    $ 147  
    

  


 

  

  



(a)   In consideration of discounts offered to certain customers for early payment for product delivered in June 2003, some receivable amounts were collected in June 2003 that otherwise would have been expected to be collected in July 2003, including $32 million from Occidental.
(b)   In consideration of discounts offered to certain customers for early payment for product delivered in March 2003, some receivable amounts were collected in March 2003 that otherwise would have been expected to be collected in April 2003, including $23 million from Lyondell and $46 million from Occidental.

 

14


LYONDELL CHEMICAL COMPANY

LYONDELL-CITGO REFINING LP

SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)

 

     June 30,
2003


   December 31,
2002


     (Millions of dollars)
BALANCE SHEET INFORMATION              

Total current assets

   $ 259    $ 357

Property, plant and equipment, net

     1,269      1,312

Deferred charges and other assets, net

     85      88
    

  

Total assets

   $ 1,613    $ 1,757
    

  

Current maturities of long-term debt

   $ 450    $ —  

Other current liabilities

     363      514

Long-term debt

     —        450

Loans payable to partners

     264      264

Other liabilities and deferred credits

     113      126

Partners’ capital

     423      403
    

  

Total liabilities and partners’ capital

   $ 1,613    $ 1,757
    

  

 

    

For the three

months ended


   

For the six

months ended


 
     June 30,

    March 31,     June 30,

 
     2003

    2002

    2003

    2003

    2002

 
     (Millions of dollars)  
INCOME STATEMENT INFORMATION                                         

Sales and other operating revenues (a)

   $ 905     $ 838     $ 1,183     $ 2,088     $ 1,545  

Operating costs and expenses:

                                        

Cost of sales

     822       754       1,133       1,955       1,400  

Selling, general and administrative expenses

     16       14       12       28       26  
    


 


 


 


 


Operating income

     67       70       38       105       119  

Interest expense, net

     (9 )     (7 )     (10 )     (19 )     (15 )
    


 


 


 


 


Net income (b)

   $ 58     $ 63     $ 28     $ 86     $ 104  
    


 


 


 


 


OTHER INFORMATION

                                        

Cash flow from operations

   $ 111     $ 67     $ 58     $ 169     $ 128  

Capital expenditures

     13       20       15       28       42  

Depreciation and amortization

     29       30       28       57       59  

EBITDA

   $ 96     $ 100     $ 66     $ 162     $ 178  

SELECTED OPERATING INFORMATION

                                        

Sales Volumes (including intersegment sales) (a)

                                        

Refined products (thousand barrels per day):

                                        

Gasoline

     113       120       113       113       113  

Diesel and heating oil

     86       83       78       82       82  

Jet fuel

     16       14       21       19       18  

Aromatics

     7       9       9       8       9  

Other refinery products

     99       100       83       90       105  
    


 


 


 


 


Total refined products volumes

     321       326       304       312       327  
    


 


 


 


 


Refinery Runs

                                        

Crude processing rates (thousand barrels per day):

                                        

Crude Supply Agreement

     246       201       194       220       215  

Other crude oil

     28       58       52       40       45  
    


 


 


 


 


Total crude oil

     274       259       246       260       260  
    


 


 


 


 



(a)   Includes revenues and volumes from sales to affiliates.
(b)   As a partnership, LCR is not subject to federal income taxes.

 

15


LYONDELL CHEMICAL COMPANY

SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED)

(Millions of dollars)

 

DAYS OF WORKING CAPITAL

 

Lyondell    June 30,
2003


    March 31,
2003


    December 31,
2002


 

Working Capital: (a)

                        

Accounts receivable

   $ 381     $ 412     $ 396  

Inventories

     366       352       344  

Accounts payable (b)

     (396 )     (384 )     (344 )
    


 


 


Total

     351       380       396  

Add: Accounts receivable sold

     81       81       65  
    


 


 


Adjusted working capital

   $ 432     $ 461     $ 461  
    


 


 


Days of Working Capital:

                        

Sales and other operating revenues for the three months ended

   $ 913     $ 989     $ 890  

Number of days in quarter

     91       90       92  

Sales per day

   $ 10.0     $ 11.0     $ 9.7  

Days of working capital (b) (c)

     43       42       48  

Equistar

                        

Working Capital: (a)

                        

Accounts receivable (d) (e)

   $ 559     $ 563     $ 625  

Inventories

     478       461       424  

Accounts payable

     (482 )     (519 )     (459 )
    


 


 


Total

     555       505       590  

Add: Accounts receivable sold

     100       96       81  
    


 


 


Adjusted working capital

   $ 655     $ 601     $ 671  
    


 


 


Days of Working Capital:

                        

Quarterly sales revenue for the three months ended

   $ 1,597     $ 1,641     $ 1,431  

Number of days in quarter

     91       90       92  

Sales per day

   $ 17.5     $ 18.2     $ 15.6  

Days of working capital (c) (d) (e)

     37       33       43  

(a)   Defined as the major controllable components of working capital—receivables, inventories and payables. Receivables sold are added back for consistency as such amounts are included in sales and in the sales per day calculation. Management believes that this provides useful information to investors because it reflects Lyondell’s and Equistar’s responsibility for administration and collection of said amounts.
(b)   In March 2003, in consideration of discounts offered by Equistar for early payment, Lyondell paid certain Equistar product invoices totaling $23 million for product delivered in March 2003. Such amounts otherwise would have been expected to be paid in April 2003 and would have reduced days of working capital as of March 31, 2003 to 40 days.
(c)   Days of working capital are calculated as adjusted working capital divided by sales per day.
(d)   In consideration of discounts offered to certain customers for early payment for product delivered in June 2003, some receivable amounts were collected in June 2003 that otherwise would have been expected to be collected in July 2003, including $32 million from Occidental. Had such amounts been collected in July 2003, days of working capital as of June 30, 2003 would have been 39 days.
(e)   In consideration of discounts offered to certain customers for early payment for product delivered in March 2003, some receivable amounts were collected in March 2003 that otherwise would have been expected to be collected in April 2003, including $23 million from Lyondell and $46 million from Occidental. Had such amounts been collected in April 2003, days of working capital as of March 31, 2003 would have been 37 days.

 

16